Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) Stake Lowered by Inspire Advisors LLC

Inspire Advisors LLC reduced its stake in shares of Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Free Report) by 50.9% during the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 6,115 shares of the company’s stock after selling 6,342 shares during the period. Inspire […]

Related Keywords

United States ,America ,Raymond James ,Pascal Deschatelets ,Alec Machiels ,Vanguard Group Inc ,T Rowe Price Investment Management Inc ,Quarter For Apellis Pharmaceuticals ,Pricet Rowe Associates Inc ,Apellis Pharmaceuticals Stock Performance ,Securities Exchange Commission ,Blackrock Inc ,News Ratings For Apellis Pharmaceuticals Daily ,Apellis Pharmaceuticals ,Apellis Pharmaceuticals Inc ,Citigroup ,Avoro Capital Advisors ,Nasdaq ,Inspire Advisors ,Free Report ,Capital Advisors ,Rowe Price Investment Management ,Pricet Rowe Associates ,Get Free Report ,Director Alec Machiels ,Exchange Commission ,Apellis Pharmaceuticals Daily ,Nasdaq Apls ,Apls ,Medical ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,